Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Boehringer Forms Stem Cell Collaboration with China Southeast University

publication date: Nov 28, 2016
Germany's Boehringer Ingelheim announced a joint research project to treat hearing loss with China Southeast University Institute of Life Sciences in Nanjing. The collaboration combines the work of Professor Renjie Chai at the Institute on the use of stem cells to regrow inner ear hair cells with BI's drug R&D experience. The venture is BI's first human research project in China, and its second Research Beyond Borders project, both of which address hearing loss. BI started the RBB initiative to expand its R&D beyond the company's core treatment areas. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital